Factor Xa inhibitors can cause recurrent intracranial hemorrhage in high-risk patients with atrial fibrillation, highlighting the need for careful observation even when switching between agents in this class.
Recurrent ICH after switching Factor Xa inhibitors may signal class risk in high-risk AF; this case report leaves optimal strategies open.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Takagishi et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: